Diagnosing Acute Liver Failure in Dengue Patients
Diagnose acute liver failure in dengue patients by documenting a prothrombin time (PT) ratio < 50% combined with hepatic encephalopathy in a patient without pre-existing liver disease, alongside markedly elevated transaminases (typically AST > ALT, often > 10 times normal) and dengue confirmation by serology or PCR.
Core Diagnostic Criteria
The diagnosis requires meeting the standard definition of acute liver failure adapted to the dengue context 1:
- Coagulopathy: PT ratio < 50% (or INR significantly elevated)
- Hepatic encephalopathy: Any grade of altered mental status attributable to liver dysfunction
- Rapid progression: Typically develops 5-7.5 days after fever onset 2, 3
- No pre-existing chronic liver disease (unless acute-on-chronic presentation)
Essential Laboratory Investigations
Immediate blood analysis should include 1:
- PT/INR and Factor V levels - the primary markers defining severity
- Liver transaminases (AST, ALT) - expect AST > 2000 U/L in severe cases 4
- Total and direct bilirubin - often markedly elevated
- Serum albumin - low levels predict poor prognosis 4, 2
- Arterial blood gas and lactate - assess metabolic derangement
- Arterial ammonia - correlates with encephalopathy severity
- Blood glucose - monitor every 2 hours for hypoglycemia
- Serum creatinine - elevated levels predict mortality 4, 2
- Complete blood count - thrombocytopenia < 50,000/mm³ is a risk factor 3
Dengue-Specific Confirmatory Testing
Confirm dengue infection through:
- Dengue serology (IgM/IgG) or NS1 antigen
- Dengue PCR if available
- Document atypical lymphocytes > 10% (associated with ALF risk) 3
Severity Assessment Tools
The MELD score ≥ 15 predicts acute liver failure development with excellent performance (AUROC 0.917, sensitivity 90%, specificity 88.4%) 4. A MELD score ≥ 18 predicts in-hospital death (AUROC 0.823) 4.
Alternative simpler scoring:
- EZ-ALBI score ≥ -30 also predicts ALF and death effectively (AUROC 0.835 for ALF) 4
- Standard ALBI score ≥ -2 shows good predictive value 4
Imaging and Additional Studies
Perform hepatic Doppler ultrasound and echocardiography 1 to:
- Exclude biliary obstruction or vascular causes
- Assess hepatomegaly (present in 60-90% of severe dengue hepatitis) 5
- Evaluate hemodynamic status and cardiac function
Exclude Alternative or Concurrent Etiologies
- Hepatitis A, B, C, E serology (IgM VHA, HBsAg, anti-HBc IgM, HEV in endemic areas)
- Herpes simplex virus and varicella zoster testing (HSV DNA, VZV serology) 6, 7
- Acetaminophen levels - even if dengue confirmed
- Toxicology screen (amphetamines, cocaine)
- Wilson disease markers if age < 40 years (ceruloplasmin, serum copper) 6
- Autoimmune hepatitis markers (ANA, ASMA, immunoglobulins) 6
Prognostic Indicators of Poor Outcome
High-risk features predicting mortality 4, 2:
- Serum creatinine elevation (acute kidney injury)
- Albumin < 3.0 g/dL
- Multi-organ dysfunction (cardiovascular, renal, neurological)
- Platelet count < 50,000/mm³
- Age ≤ 40 years paradoxically increases risk 3
Role of Liver Biopsy
Liver biopsy is NOT routinely recommended 7 in dengue-associated ALF due to:
- Severe coagulopathy making procedure high-risk
- Thrombocytopenia
- Diagnosis can be established clinically and serologically
Consider biopsy only if:
- Diagnosis remains uncertain after complete workup
- Autoimmune hepatitis or other treatable etiology suspected
- Coagulopathy can be temporarily corrected
Clinical Pitfalls to Avoid
Do not wait for encephalopathy to develop before recognizing severe hepatitis - monitor PT ratio closely as it falls below 50% 1
Do not attribute all liver dysfunction to dengue - systematically exclude HSV, hepatitis viruses, and drug-induced injury 6, 7
Recognize that dengue ALF typically occurs in the defervescence phase (days 5-7.5), not during acute fever 2, 3
Monitor for acute-on-chronic presentations - patients may have unrecognized underlying liver disease 1
Serial monitoring is essential - single normal values do not exclude progression; check transaminases, PT/INR, and platelets at least daily in severe dengue 1
The diagnosis is ultimately clinical, combining dengue confirmation with standard ALF criteria, while the provided laboratory parameters and scoring systems enable early risk stratification before fulminant failure develops 4, 3.